论文部分内容阅读
我们自1986年以来应用超大剂量维脑路通液治疗脑血栓形成40例,取得较好疗效,现报道如下。临床资料一般资料:按1978年第二届全国神经精神科学术会议制定的标准,排除TFA及轻型脑出血等恶性脑血管病后,共诊断脑血栓形成82例,随机分为两组;超大量维脑路通治疗组(观察组)与治疗量维脑路通治疗组(对照组)。观察组40例中男性24例,女16例,年龄最小45岁,最大73岁,平均64岁。发病至用药时间最短26小时,最长32天,以3至7天内给药者最多。对照组42例中男25例,女17例,最小年龄47岁,最大71岁,平均年龄62岁。发病至用药时间,最短6小时,最长21天,以2至6天内给药者最多,主要症状和体征见表1。两组资料大致相同,有可比性。治疗方法:观察组用10％葡萄糖500～1000毫升加入维脑路通注射液(太原第二制药厂产)1000～2000毫克静脉点滴,每日一次,连续14天为一疗程,间隔5至7天进行第二疗程.对照组每日用
We since 1986, application of large doses of Venoruton in the treatment of cerebral thrombosis in 40 cases, and achieved good results, are reported below. General information on clinical data: According to the criteria set by the Second National Neuropsychiatric Conference in 1978, 82 cases of cerebral thrombosis were diagnosed after TFA and light cerebral hemorrhage and other malignant cerebrovascular diseases were excluded and randomly divided into two groups. Weiluolutong treatment group (observation group) and treatment of Weiluolutong treatment group (control group). Observation group of 40 cases, 24 males and 16 females, the youngest 45 years old, maximum 73 years old, average 64 years old. The incidence of medication to the shortest 26 hours, up to 32 days to 3 to 7 days to give the most. The control group of 42 patients, 25 males and 17 females, the youngest age of 47 years, the maximum age of 71, the average age of 62 years. The incidence of medication time, the shortest 6 hours, up to 21 days to 2 to 6 days to give the most patients, the main symptoms and signs in Table 1. The two groups of data are roughly the same, comparable. Treatment: The observation group with 10% glucose 500 ~ 1000 ml added Venoruton injection (Taiyuan Pharmaceutical Factory production) 1000 ~ 2000 mg intravenously once daily for 14 days for a course of treatment, an interval of 5 to 7 Day for the second course of treatment daily control group